Antisense modulation of CD44 expression |
| OF THE INVENTION The present invention employs oligomeric antisense compounds, particularly ... |
|
Antisense modulation of Smad7 expression |
| OF THE INVENTION The present invention employs oligomeric antisense compounds, particularly ... |
|
Antisense modulation of nucleolin expression |
| OF THE INVENTION The present invention employs oligomeric antisense compounds, particularly ... |
|
Antisense modulation of hnRNP A1 expression |
| OF THE INVENTION The present invention employs oligomeric antisense compounds, particularly ... |
|
Antisense inhibition of E2F transcription factor 3 expression |
| OF THE INVENTION The present invention employs oligomeric antisense compounds, particularly ... |
|
Antisense inhibition of rank expression |
| OF THE INVENTION The present invention employs oligomeric antisense compounds, particularly ... |
|
Antisense inhibition of protein kinase C-theta expression |
| OF THE INVENTION The present invention employs oligomeric antisense compounds, particularly ... |
|
Antisense oligonucleotide modulation of human mdm2 expression |
| OF THE INVENTION Tumors often result from genetic changes in cellular regulatory genes. Among the ... |
|
Antibacterial agents comprising conjugates of glycopeptides and peptidic membrane associating elements |
| What is claimed is: 1. An antibacterial compound of formula V-L-W-X; wherein: V is a glycopeptide ... |
|
|
Use of microparticles combined with submicron oil-in-water emulsions
| Details |
Inventors: O'Hagan, Derek; Van Nest, Gary; Ott, Gary S.; Singh, Manmohan;
Assignee: Chiron Corporation (Emeryville, CA)
Primary Examiner: Woodward; Michael P.
Assistant Examiner: Zeman; Mary K
Attorney, Agent or Firm: Robins and Associates, Harbin; Alisa, Blackburn; Robert P.
Compositions are provided which include biodegradable microparticles with entrapped or adsorbed antigens, in combination with submicron oil-in-water emulsions. Also provided are methods of immunization which comprise administering to a vertebrate subject (a) a submicron oil-in-water emulsion, and (b) a therapeutically effective amount of a selected antigen entrapped in a microparticle. |
|
DETAILED DESCRIPTION OF THE INVENTION The practice of the present invention will employ, unless otherwise indicated, conventional methods of chemistry, biochemistry, molecular biology, immunology and pharmacology, within the skill of the art. Such techniques are explained fully in the literature. See, e. g. , Remington's Pharmaceutical Sciences, 18th Edition (Easton, Pa. : Mack Publishing Company, 1990); Methods In Enzymology (S. Colowick and N. Kaplan, eds. , Academic Press, Inc. ); and Handbook of Experimental Immunology, Vols. I-IV (D. M. Weir and C. C. Blackwell, eds. , 1986, Blackwell Scientific Publications); and Sambrook, et al. , Molecular Cloning: A Laboratory Manual (2nd Edition, 1989). All publications, patents and patent applications cited herein, whether supra or infra, are hereby incorporated by reference in their entirety. As used in this specification and the appended claims, the singular forms "a," "an" and "the" include plural references unless the content clearly dictates otherwise. I. Definitions In describing the present invention, the following terms will be employed, and are intended to be defined as indicated below. The term "microparticle" as used herein, refers to a particle of about 100 nm to about 150 . mu. m in diameter, more preferably about 200 nm to about 30 . mu. m in diameter, and most preferably about 500 nm to about 10 . mu. m in diameter. Preferably, the microparticle will be of a diameter that permits parenteral administration without occluding needles and capillaries. Microparticle size is readily determined by techniques well known in the art, such as photon correlation spectroscopy, laser diffractometry and/or scanning electron microscopy. Microparticles for use herein will be formed from materials that are sterilizable, non-toxic and biodegradable. Such materials include, without limitation, poly(. alpha. -hydroxy acid), polyhydroxybutyric acid, polycaprolactone, polyorthoester, polyanhydride. Preferably, microparticles for use with the present invention are derived from a poly(
|
| Related patents |
|
|
Methods of treating hypertension and compositions for use therein
The present invention provides methods of treating hypertension, particularly essential hypertension. The methods generally involve providing a stimulator of ...
|
|
|
Use of microparticles combined with submicron oil-in-water emulsions
OF THE INVENTION The practice of the present invention will employ, unless otherwise indicated, conventional methods of chemistry, biochemistry, molecular biology, ...
|
|
|
6,11-bicyclic erythromycin derivatives
OF THE INVENTION A first embodiment of the present invention is a compound of formula I as defined herein, or its pharmaceutically acceptable salt, ester, or prodrug. R...
|
|
|
Method of producing infectious reovirus
OF THE INVENTION The present invention is directed to a method of producing mammalian reovirus by using human embryo kidney 293 (HEK 293) cells. We found that HEK 293 ...
|
|
|
CDNA sequences of human bone matrix proteins
It is, therefore, an object of the present invention to provide specific cDNA and deduced protein sequences which are diagnostic of such human diseases as osteoporosis, ...
|
|
|
Antisense inhibition of PEPCK-mitochondrial expression
OF THE INVENTION The present invention employs oligomeric antisense compounds, particularly oligonucleotides, for use in modulating the function of nucleic acid ...
|
|
|
Methods of modulating tumor necrosis factor .alpha.-induced expression of cell adhesion molecules
OF THE INVENTION The present invention employs specific inhibitors of Ha-ras, c-raf and JNK2, members of the TNF-.alpha. signaling pathway, to modulate cell adhesion ...
|
|
|
Antisense modulation of telomeric repeat binding factor 1 expression
OF THE INVENTION The present invention employs oligomeric antisense compounds, particularly oligonucleotides, for use in modulating the function of nucleic acid ...
|
|
|
Antisense modulation of interleukin-5 signal transduction
OF THE INVENTION The present invention comprehends antisense compounds capable of modulating IL-5 signal transduction, preferably by modulating expression of IL-5 or IL-...
|
|
|
Antisense modulation of P38 mitogen activated protein kinase expression
OF THE INVENTION p38 MAPKs play an important role in signal transduction in response to cytokines, growth factors and other cellular stimuli. Specific responses ...
|
|
|